Speaker Profile

Ph.D., Chief Scientific Officer, Abpro

Gavin MacBeath, PhD is currently the Chief Scientific Officer at Abpro, where he oversees antibody-based therapeutics programs focused on immuno-oncology, eye disease, and autoimmunity. At Abpro, Dr. MacBeath is combining their deep expertise in antibody generation with a suite of bispecific antibody engineering approaches to develop a broad pipeline of immune cell engagers, as well as molecules that modulate fibrosis and angiogenesis. Previously, Dr. MacBeath was a founder of Merrimack Pharmaceuticals, where he served as SVP of Discovery and Head of Translational Medicine (2010-2016). Prior to joining Merrimack, Dr. MacBeath served as faculty in the Department of Chemistry and Chemical Biology at Harvard University (2002-2010), most recently as Associate Professor. Dr. MacBeath holds a Bachelor of Science Degree in Genetics from the University of Manitoba, Canada (1991) and a PhD in Macromolecular and Cellular Structure and Chemistry from The Scripps Research Institute in La Jolla, CA (1998).

Don't Miss Important Precision Medicine Updates

PMWC is the most comprehensive precision medicine conference. To receive the lastest news and updates from the field, subscribe to the newsletter here.

View the top 3 talks from PMWC here (password: top-videos).